Abstract:Programmed cell death (PCD) is an essential part of organismal development and plays fundamental roles in host defense against pathogens and the maintenance of homeostasis. However, excess activation of PCD pathways has proven to be detrimental and can drive disease. Additionally, resistance to PCD can also contribute to disease development. Modulation of PCD, therefore, has great therapeutic potential in a wide range of diseases, including infectious, neurodegenerative, autoinflammatory, and metabolic diseases and cancer. Nevertheless, manipulation of cell death and inflammation for therapeutic intervention is a delicate process, highly specific to the context of the disease of interest, making the selection of the appropriate target molecule crucially important. Several PCD pathways are associated with innate immunity, including pyroptosis, apoptosis, necroptosis, and PANoptosis, which is defined as an inflammatory PCD pathway with key features of pyroptosis, apoptosis, and/or necroptosis that cannot be accounted for by any of these three PCD pathways alone. All of these PCD pathways are regulated by upstream sensors and signaling cascades that assemble multimeric complexes to serve as activation platforms for downstream molecules; these sensors and signaling molecules provide attractive target points for therapeutic intervention. Here, we discuss the molecular mechanisms of innate immune-mediated cell death in health and disease, with a particular focus on the molecules putatively involved in the formation of the PANoptosome and the induction of inflammatory cell death. Further, we discuss the implications and feasibility of targeting these molecules to improve disease outcomes, as well as current clinical approaches.

Emerging connectivity of programmed cell death pathways and its physiological implications

Programmed cell death in plants: lessons from bacteria?

Programming inflammatory cell death for therapy

Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis

Programmed Cell Death and Cancer

Programmed cell death in tumor immunity: mechanistic insights and clinical implications

Programmed Cell Death Tunes Tumor Immunity

The Mechanisms of Regulated Cell Death: Structural and Functional Proteomic Pathways Induced or Inhibited by a Specific Protein-A Narrative Review

From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways

Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Navigating the complexities of cell death: Insights into accidental and programmed cell death

Cell death pathways: intricate connections and disease implications

Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets

Programmed Cell Death, from a Cancer Perspective: An Overview

The Antisocial Network: Cross Talk Between Cell Death Programs in Host Defense

Programmed cell death as a defence against infection

Implications of inflammatory cell death-PANoptosis in health and disease

Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death

The evolution of regulated cell death pathways in animals and their evasion by pathogens